Statin (3-Hydroxy-3-Methylglutaryl-Coenzyme a Reductase Inhibitor)-Based Therapy for Hepatitis C Virus (HCV) Infection-Related Diseases in the Era of Direct-Acting Antiviral Agents

F1000Research - United Kingdom
doi 10.12688/f1000research.7970.3

Related search